DOCSLIB.ORG

Clinician's Guide to Treating Tobacco Dependence

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Clinician's Guide to Treating Tobacco Dependence Clinician’s Guide to Treating Tobacco Dependence Produced by members of the AARC Tobacco-Free Lifestyle Roundtable with a forward by Dr. Steven Schroeder American Association for Respiratory Care 1 Clinician‘s Guide to Tobacco Dependence Clinician’s Guide to Treating Tobacco Dependence Produced by members of the AARC Tobacco-Free Lifestyle Roundtable With a Foreword by Dr. Steven Schroeder Copyright ©2014 by the American Association for Respiratory Care Produced by the American Association for Respiratory Care 2 Clinician‘s Guide to Tobacco Dependence Table of Contents Foreword ................................ 5 The Evidence and Special Populations ........ 31 Effect of Nicotine on the Human Body ......... 6 Myocardial Infarction and Cardiac Issues Cardiopulmonary Involvement Pregnant Smokers Psychoactive Involvement Hospitalized Tobacco Users Effect on Weight and Appetite Secondhand and Thirdhand Smoke Other Effects Teen and Pre-teen Tobacco Products ......................... 8 System-wide Implementation and Policy Development ................... 39 The Cigarette as a Drug-delivery System The Joint Commission’s New Menthol Tobacco Measure Set Light Cigarettes Steps to Implementing a Tobacco-cessation Program Cigars and Cigarillos Respiratory Care Educator Role Miscellaneous Products .................... 10 Reimbursement for Smoking and Electronic Cigarettes Tobacco Cessation and Counseling ........... 45 Hookah Smoking Referral: Outpatient and Community Programs . 48 Smokeless Tobacco and Snus References .............................. 50 Neurochemistry of Addiction ............... 13 Acronyms ............................... 53 Chain of Addiction ....................... 14 List of Figures and Tables DSM 5 Nicotine Dependence Criteria ......... 15 Table 1 . DSM 5 Severity of Disorder Criteria . 16 Starting the Conversation .................. 17 Table 2 . Nicotine Replacement Therapy (NRT) 5 A’s, 5 R’s, and the Condensed Over-the-Counter Pharmacotherapy Options . 28 AAR Tobacco Intervention ................. 18 Table 3 . Nicotine Replacement Therapy (NRT) Motivational Interviewing . 23 Prescription Pharmacotherapy Options . .29 What Is Motivational Interviewing? Table 4 . Non-NRT Pharmacotherapy Options . .. 30 How Does Motivational Interviewing Table 5 . Pharmacotherapy Options for Patients Work? with Cardiovascular Disease . 32 Example of a Brief Motivational Table 6 . Suggested Interventions for Interviewing Conversation Hospitalized Patients . .. 36 Pharmacotherapy ........................ 27 Table 7 . Tobacco Measure Set Specifications . 40 Nicotine Replacement Therapy Figure 1 . 5 A’s . 18 Bupropion Figure 2 . Stages of Change . 20 Varenicline Figure 3 . Example of Readiness to Change/Confidence to Change Now Scale . .. 24 3 Clinician‘s Guide to Tobacco Dependence Program Faculty Georgianna Sergakis, PhD, RRT, CTTS Courtney Seibert, BS, RRT-NPS Chairperson, Clinician’s Guide to Treating Dayton Children’s Hospital Tobacco Dependence Dayton, OH The Ohio State University Columbus, OH Shawna Strickland, PhD, RRT-NPS, AE-C, FAARC American Association for Respiratory Care Erna Boone, DrPH, RRT, FAARC Irving, TX University of Arkansas for Medical Sciences Little Rock, AR Jay Taylor, RRT, CTTS Sanford Medical Center Scott Cerreta, BS, RRT Fargo, ND COPD Foundation Washington, DC Sarah Varekojis, PhD, RRT The Ohio State University Crystal Dunlevy, EdD, RRT Columbus, OH The Ohio State University Columbus, OH Jonathan Waugh, PhD, RRT, RPFT, CTTS, FAARC University of Alabama at Birmingham Robert Fluck Jr., MS, RRT, FAARC Birmingham, AL SUNY Upstate Medical University, Retired Syracuse, NY With a foreword written by Steven Schroeder, MD Susan Rinaldo-Gallo, MEd, RRT, CTTS, FAARC Professor, Department of Medicine Duke University Hospital Director, Smoking Cessation Leadership Center Durham, NC Distinguished Professorship in Health and Health Care Grace Howard, BSRT, RRT University of California, San Francisco Cleveland Clinic San Francisco, CA Cleveland, OH Kathryn Ickes, BS, RRT, RPFT, AE-C Cleveland Clinic Cleveland, OH Gaylene Lee, MEd, RRT-NPS, TTS Concorde Career College San Antonio, TX Mary Martinasek, PhD, RRT-NPS, CHES, AE-C University of Tampa Tampa, FL Karen S. Schell, DHSc, RRT-NPS, RRT-SDS, RPFT, RPSGT, AE-C, CTTS Newman Regional Health Emporia, KS 4 Clinician‘s Guide to Tobacco Dependence Foreword 2014 was a landmark year in tobacco control in the United are available over the States, marking the 50th anniversary of the first Surgeon counter, while the spray and General’s Report on Smoking and Health. In the intervening inhaler require a prescrip- five decades, the United States has seen great progress in tion. Two oral medications, reducing smoking rates and the ravages of smoking-related bupropion and varenicline, diseases. Yet, tobacco use remains the number one killer, are also effective. accounting for almost 500,000 annual deaths in the United States and 5 million worldwide. Respiratory therapists (RTs) It is easy to be discour- are uniquely positioned to address this problem, given their aged because many smokers frequent contact with smokers who have smoking-induced dis- are unable to quit, even eases, and their special trusted position as bed-side clinicians those with serious smok- with intimate patient contact. ing-induced diseases such as COPD and coronary disease. What are the facts? There are about 42 million smokers in Even the most successful tri- the United States today, of whom 80% smoke on a daily basis als of counseling combined and 20% only intermittently. Just as the prevalence of adult with medications yield quit smoking has gradually declined—from 42.7% in 1964 to 18% rates of 25% or less. This is today—so too has the amount of daily cigarettes smoked by a great improvement over smokers—from 20 per day to about 13 per day. Tobacco use, the spontaneous “cold turkey” quit rate of about 4%, but still especially combustible tobacco such as cigarettes and cigars, means that success comes hard. But RTs should take this as a exert a devastating toll on personal health, both for smokers challenge. Most successful quitters have previously failed 8 to and for nonsmokers exposed to secondhand smoke. The asso- 12 quit attempts before finally quitting. There are now more ciation between smoking and lung cancer is well known, as ex-smokers than current ones. And the potential health bene- is the linkage between smoking and heart disease and stroke. fits are immense. Not only do former smokers live longer, they The list of other diseases that are more likely to occur in smok- also live healthier lives, as respiratory and cardiac symptoms ers expands every year. It includes multiple types of cancer, recede. An added bonus of quitting is that it eliminates the chronic obstructive pulmonary disease, diabetes, and—most burden of secondhand smoke exposure to family and friends, recently—Alzheimer’s dementia. with the attendant risk of myocardial infarction and stroke. Over time, persons in higher socio-economic classes have RTs may be asked about the electronic cigarette, now avail- abandoned smoking, which is now concentrated in the less able in scores of formats. It is important to note that these fortunate, including populations with mental health and/or products are evolving continuously, and that data about their substance use disorders, the homeless, and those involved risk and potential to help smokers quit are incomplete and also with the criminal justice system. Medical workers now have dated by dint of the changing technology. In general, it is pru- much lower smoking rates than the general population. Only dent to say that the risks and potential benefits of the e-cig- about 1% of physicians smoke, and professions with previous arette are unproven, that it is likely that they are less harmful high rates such as RTs and nurses now have smoking preva- than combustible tobacco but not entirely harmless, and that lence rates of 11% and 7%, respectively. their potential to help smokers quit is unknown but less than the combination of counseling and FDA-approved medications. RTs understand that it is hard to quit smoking, even when patients are motivated to do so. A major reason for this is RTs are in a unique position to help smokers quit. No other the extremely addictive nature of nicotine. But hospitaliza- action they can take compares with the clinical impact of tion provides an excellent opportunity to help smokers quit. stopping smoking. Read this guide carefully, use it for your There are now a number of evidence-based treatments that patients, and thereby improve the health of the nation! have been shown to increase the probability of quitting. These start with the simple recommendation from trusted clinicians. Steven A. Schroeder, MD Counseling, either in-person or via toll-free telephone quitlines, Professor, Department of Medicine accessed via 1-800-QUITNOW, is effective. Seven forms of Director, Smoking Cessation Leadership Center FDA-approved medications have been proven to increase quit Distinguished Professorship in Health and Health Care rates. Five of these are nicotine replacement products—the University of California, San Francisco patch, gum, lozenge, nasal spray, and inhaler; the first three 5 Clinician‘s Guide to Tobacco Dependence Effect of Nicotine on the Human Body Nicotine affects numerous systems and pathways although a majority of the studies excluded in the human body, the consequences of which patients with baseline cardiac disease.3 can be seen in the many patients and clients
Load more

Recommended publications
  • Flavored Tobacco Products, Effective As of January 1, 2021
    ORDINANCE NO. ______ (CODE AMENDMENT NO. 772) AN ORDINANCE OF THE CITY COUNCIL OF THE CITY OF EL MONTE AMENDING CHAPTER 8.10 (RETAIL SALES OF TOBACCO PRODUCTS) OF TITLE 8 (HEALTH AND SAFETY) OF THE EL MONTE MUNICIPAL CODE TO PROHIBIT THE SALE OF FLAVORED TOBACCO PRODUCTS, EFFECTIVE AS OF JANUARY 1, 2021 WHEREAS, the potential failure of tobacco retailers to comply with tobacco control laws, particularly laws prohibiting the sale of tobacco products to minors, presents a threat to the public health, safety, and welfare of the residents of the City of El Monte (the “City”); WHEREAS, the federal Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act), enacted in 2009, prohibited candy- and fruit-flavored cigarettes,i largely because these flavored products were marketed to youth and young adults,ii and younger smokers were more likely than older smokers to have tried these products;iii WHEREAS, although the manufacture and distribution of flavored cigarettes (excluding menthol) are banned by federal law,iv neither federal law nor California law restricts the sale of menthol cigarettes or flavored non-cigarette tobacco products, such as cigars, cigarillos, smokeless tobacco, hookah tobacco, electronic smoking devices, and the solutions used in these devices; WHEREAS, flavored tobacco products are very common in California tobacco retailers as evidenced by the following: • 97.4% of stores that sell cigarettes sell menthol cigarettes;v • 94.5% of stores that sell little cigars sell them in flavored varieties;vi • 84.2% of stores
    [Show full text]
  • Snus: the Original Reduced-Harm Tobacco Product
    * Snus: the original reduced-harm tobacco product Although not risk-free independent evidence1,2 less harmful than cigarettes suggests it’s 95-99% Consumed orally by Used for centuries in placing under the lip Scandinavia* Smokeless, so lacks the Gentle heating during harmful toxicants and manufacture reduces the number carcinogens associated with of cancer-causing chemicals cigarette combustion that form in the tobacco Snus is currently banned across the EU, except in Sweden where it originates This is preventing millions of smokers from experiencing its potential harm reduction benefits NORWAY SWEDEN EU Average Thanks to the popularity of Sweden snus as a cigarette substitute, SWEDEN 24% 5% Sweden enjoys the lowest smoking rate in Europe (5%)3,4 Achieving a smoking rate of >5% is the goal of multiple European states by 2040.5 5% Thanks to snus, Sweden is decades ahead of the majority of its fellow members NORWAY Only 10% of Swedish snus 6 users also smoke cigarettes Snus is legal in More adults in Norway suggesting its potential ability Norway as it isn’t an use snus than smoke to fully ‘off-ramp’ adult smokers EU member state 12% vs. 11%10 Snus is typically used by more UK Royal College of men than women, although Physicians it’s becoming increasingly “In Norway, snus is popular with both genders7 Similar to Sweden, dual use of snus and associated with smoking cigarettes is low11 cessation”4 Primarily owing to snus, Sweden Average EU Sweden’s male adult tobacco consumption is actually slightly *Contemporary snus has evolved from an early precursor product, first used in Sweden over 300 years ago 26% 25% 3 1 higher than the EU average ..
    [Show full text]
  • Smoking Cessationreview Smoking Cessation YEARS Research Review MAKING EDUCATION EASY SINCE 2006
    RESEARCH Smoking CessationREVIEW Smoking Cessation YEARS Research Review MAKING EDUCATION EASY SINCE 2006 Making Education Easy Issue 24 – 2016 In this issue: Welcome to issue 24 of Smoking Cessation Research Review. Encouraging findings suggest that varenicline may increase smoking abstinence rates in light smokers Have combustible cigarettes (5–10 cigarettes per day). However, since the study was conducted in a small cohort of predominantly White met their match? cigarette smokers, it will be interesting to see whether the results can be generalised to a larger population Supporting smokers with that is more representative of the real world. depression wanting to quit Computer-generated counselling letters that target smoking reduction effectively promote future cessation, Helping smokers quit after report European researchers. Their study enrolled smokers who did not intend to quit within the next diagnosis of a potentially 6 months. At the end of this 24-month investigation, 6-month prolonged abstinence was significantly higher curable cancer amongst smokers who received individually tailored letters compared with those who underwent follow-up assessments only. Preventing postpartum return to smoking We hope you enjoy the selection in this issue, and we welcome any comments or feedback. Varenicline assists smoking Kind Regards, cessation in light smokers Brent Caldwell Natalie Walker [email protected] [email protected] Novel pMDI doubles smoking quit rates Progress towards the Smokefree 2025 goal: too slow Independent commentary by Dr Brent Caldwell. Brent Caldwell was a Senior Research Fellow at Wellington Asthma Research Group, and worked on UK data show e-cigarettes are the Inhale Study. His main research interest is in identifying and testing improved smoking cessation linked to successful quitting methods, with a particular focus on clinical trials of new smoking cessation pharmacotherapies.
    [Show full text]
  • Other Tobacco Products (OTP) Are Products Including Smokeless and “Non-Cigarette” Materials
    Other tobacco products (OTP) are products including smokeless and “non-cigarette” materials. For more information on smoking and how to quit using tobacco products, check out our page on tobacco. A tobacco user may actually absorb more nicotine from chewing tobacco or snuff than they do from a cigarette (Mayo Clinic). The health consequences of smokeless tobacco use include oral, throat and pancreatic cancer, tooth loss, gum disease and increased risk of heart disease, heart attack and stroke. (American Cancer Society, “Smokeless Tobacco” 2010) Smokeless tobacco products contain at least 28 cancer-causing agents. The risk of certain types of cancer increases with smokeless tobacco: Esophageal cancer, oral cancer (cancer of the mouth, throat, cheek, gums, lips, tongue). Other Tobacco Products (OTP) Include: Chewing/Spit Tobacco A smokeless tobacco product consumed by placing a portion of the tobacco between the cheek and gum or upper lip teeth and chewing. Must be manually crushed with the teeth to release flavor and nicotine. Spitting is required to get rid of the unwanted juices. Loose Tobacco Loose (pipe) tobacco is made of cured and dried leaves; often a mix of various types of leaves (including spiced leaves), with sweeteners and flavorings added to create an "aromatic" flavor. The tobacco used resembles cigarette tobacco, but is more moist and cut more coarsely. Pipe smoke is usually held in the mouth and then exhaled without inhaling into the lungs. Blunt Wraps Blunt wraps are hollowed out tobacco leaf to be filled by the consumer with tobacco (or other drugs) and comes in different flavors. Flavors are added to create aromas and flavors.
    [Show full text]
  • Snus: a Compelling Harm Reduction Alternative to Cigarettes Elizabeth Clarke1* , Keith Thompson2, Sarah Weaver1, Joseph Thompson1 and Grant O’Connell1
    Clarke et al. Harm Reduction Journal (2019) 16:62 https://doi.org/10.1186/s12954-019-0335-1 REVIEW Open Access Snus: a compelling harm reduction alternative to cigarettes Elizabeth Clarke1* , Keith Thompson2, Sarah Weaver1, Joseph Thompson1 and Grant O’Connell1 Abstract Snus is an oral smokeless tobacco product which is usually placed behind the upper lip, either in a loose form or in portioned sachets, and is primarily used in Sweden and Norway. The purpose of this review is to examine the reported effects of snus use in relation to specified health effects, namely lung cancer, cardiovascular disease, pancreatic cancer, diabetes, oral cancer and non-neoplastic oral disease. The review also examines the harm reduction potential of snus as an alternative to cigarettes by comparing the prevalence of snus use and cigarette smoking, and the reported incidence of tobacco-related diseases across European Union countries. The scientific literature generally indicates that the use of snus is not a significant risk factor for developing lung cancer, cardiovascular disease, pancreatic cancer or oral cancer. Studies investigating snus use and diabetes have reported that high consumption of snus (estimated as being four or more cans per week) may be associated with a higher risk of developing diabetes or components of metabolic syndrome; however, overall results are not conclusive. Snus use is associated with the presence of non-neoplastic oral mucosal lesions which are reported to heal rapidly once use has stopped. The most recent Eurobarometer data from 2017 reported that Sweden had thelowestprevalenceofdailycigaretteuseintheEuropeanUnionat5%whilstdaily“oral tobacco” use was reported to be 20%.
    [Show full text]
  • Healthy Mouth, Healthy You the Connection Between Oral and Overall Health
    Healthy Mouth, Healthy You The connection between oral and overall health Your dental health is part of a bigger picture: whole-body wellness. Learn more about the relationship between your teeth, gums and the rest of your body. We keep you smiling® deltadentalins.com/enrollees Pregnancy Pregnancy is a crucial time to take care of your oral health. Hormonal changes may increase the risk of gingivitis, or inflammation of the gums. Symptoms include tenderness, swelling and bleeding of the gums. Without proper care, these problems may become more serious and can lead to gum disease. Gum disease is linked to premature birth and low birth weight. If you notice any changes in your mouth during pregnancy, see your dentist. WHAT YOU CAN DO • Be vigilant about your oral health. Brush twice daily and floss at least once a day — these basic oral health practices will help reduce plaque buildup and keep your mouth healthy. • Talk to your dentist. Always let your dentist know that you are pregnant. • Eat well. Choose nutritious, well-balanced meals, including fresh fruits, raw vegetables and dairy products. Athletics Sports and exercise are great ways to build muscle and improve cardiovascular health, but they can also increase risks to your oral health. Intense exercise can dry out the mouth, leading to a greater chance of tooth decay. If you play a high-impact sport without proper protection, you risk knocking out a tooth or dislocating your jaw. WHAT YOU CAN DO • Hydrate early. Prevent dehydration by drinking water during your workout — and several hours beforehand. • Skip the sports drinks.
    [Show full text]
  • July 2021 L.A. Care Health Plan Medi-Cal Dual Formulary
    L.A. Care Health Plan Medi-Cal Dual Formulary Formulary is subject to change. All previous versions of the formulary are no longer in effect. You can view the most current drug list by going to our website at http://www.lacare.org/members/getting-care/pharmacy-services For more details on available health care services, visit our website: http://www.lacare.org/members/welcome-la-care/member-documents/medi-cal LA1308E 02/20 EN lacare.org Last Updated: 07/01/2021 INTRODUCTION Foreword Te L.A. Care Health Plan (L.A. Care) Medi-Cal Dual formulary is a preferred list of covered drugs, approved by the L.A. Care Health Plan Pharmacy Quality Oversight Committee. Tis formulary applies only to outpatient drugs and self-administered drugs not covered by your Medicare Prescription Drug Beneft. It does not apply to medications used in the inpatient setting or medical ofces. Te formulary is a continually reviewed and revised list of preferred drugs based on safety, clinical efcacy, and cost-efectiveness. Te formulary is updated on a monthly basis and is efective the frst of every month. Tese updates may include, and are not limited to, the following: (i) removal of drugs and/or dosage forms, (ii) changes in tier placement of a drug that results in an increase in cost sharing, and (iii) any changes of utilization management restrictions, including any additions of these restrictions. Updated documents are available online at: lacare.org/members/getting-care/pharmacy-services. If you have questions about your pharmacy coverage, call Customer Solutions Center at 1-888-839-9909 (TTY 711), available 24 hours a day, 7 days a week.
    [Show full text]
  • NATIONAL GUIDELINES for TOBACCO CESSATION
    NATIONAL GUIDELINES For TOBACCO CESSATION Ministry of Health & Family Welfare, Govt of India TABLE OF CONTENTS Page No. 1. Introduction 3 2. Tobacco and Health 8 3. Nicotine Addiction 9 4. Tobacco Cessation Services in India-A overview 12 5. Process of Cessation--Interventional Strategies (the 5 A’s) 14 Ask Advise Assess ° Readiness to change model ° Assess Nicotine Dependence Assist ° Who are not willing/unsure to quit (5 Rs) ° Willing to quit °° Barriers of quitting °°Cognitive/behavioral/Pharmacotherapy Strategies to assist quitting ° Withdrawal Symptoms Arrange Common problems while quitting and their solution 6. Relapse prevention 34 ° Coping Tips to Stay away from Tobacco ° Type smoker/ Reasons of Tobacco use and tips to help to quit 7. Self-help intervention for tobacco cessation 37 8. Developing a plan with your client 41 9. Quit tobacco for busy physicians 42 10. Smokeless Tobacco & how to quit it 44 11. Tobacco cessation in dental Clinic 47 12. Tobacco cessation in special situation 51 13. How to start Tobacco cessation services 54 14. Pharmacotherapy 58 15. Other form of therapy 62 16. References 63 17. Appendixes 67 I - Tobacco Cessation Data Collection Form (for understanding) 1 II - Nicotine addiction questionnaire III - Handouts IV - TCC Centres V - Participants of developing guidelines 2 1. INTRODUCTION This learning module is designed to empower clinicians, health educators and counselors to provide the best behavioral modification strategy / Pharmacotherapy for tobacco cessations Tobacco use is leading cause of preventable deaths all over the world. According to WHO there are 1100 million smokers worldwide, which constitutes one-third of global population aged 15 years and above.
    [Show full text]
  • Bupropion + Patch
    Patient Guide: Combination Tobacco Cessation Therapy BUPROPION SUSTAINED RELEASE (SR) 150mg NICOTINE PATCH 21mg, 14mg, 7mg Use Daily Use As Needed What does this medication do? Bupropion is a non-nicotine aid that helps you quit smoking by reducing The patch will release small, but continuous amounts of nicotine through the withdrawal symptoms. Bupropion is recommended along with a tobacco skin. This helps to decrease withdrawal symptoms. cessation program to provide you with additional support and educational materials. How do I use it? BUPROPION SUSTAINED RELEASE (SR) 150mg NICOTINE PATCH 21mg, 14mg, 7mg Set a date when you intend to stop smoking (quit date). The medicine needs Begin using the patch on your quit date, 1-2 weeks after starting bupropion. to be started 1-2 weeks before that date. Apply only one (1) patch when you wake up and remove the old patch. Take 1 tablet daily for 3 days, then increase to 1 tablet twice daily. If you miss a dose, use it as soon as you can. Take at a similar time each day, allowing approximately 8 hours in between Peel the back off the patch and put it on clean, dry, hair-free skin on your doses. Don’t take bupropion past 5pm to avoid trouble sleeping. upper arm, chest or back. This medicine may be taken for 7-12 weeks and up to 6 months. Discuss with Press patch firmly in place for 10 seconds so it will stick well to your skin. your provider if you need to be treated longer than 12 weeks.
    [Show full text]
  • Use of Non Cigarette Tobacco Products (NCTP) Smokeless
    Non Cigarette Tobacco Products (NCTP) and Electronic cigarettes (e-cigs) Michael V. Burke EdD Asst: Professor of Medicine Nicotine Dependence Center Mayo Clinic, Rochester, MN Email: [email protected] ©2011 MFMER | slide-1 Goals & Objectives • Review NCTP definitions & products • Discuss prevalence/trends of NCTP • Discuss NCTP and addiction • Review recommended treatments for NCTP ©2011 MFMER | slide-2 NCTP Definitions & Products ©2011 MFMER | slide-3 Pipes ©2011 MFMER | slide-4 Cigars Images from www.trinketsandtrash.org ©2011 MFMER | slide-5 Cigar Definition U.S. Department of Treasury (1996): Cigar “Any roll of tobacco wrapped in leaf tobacco or any substance containing tobacco.” vs. Cigarette “Any roll of tobacco wrapped in paper or in any substance not containing tobacco.” ©2011 MFMER | slide-6 NCI Monograph 9. Cigars: Health Effects and Trends. ©2011 MFMER | slide-7 ©2011 MFMER | slide-8 Smokeless Tobacco Chewing tobacco • Loose leaf (i.e., Redman) • Plugs • Twists Snuff • Moist (i.e., Copenhagen, Skoal) • Dry (i.e., Honest, Honey bee, Navy, Square) ©2011 MFMER | slide-9 “Chewing Tobacco” = Cut tobacco leaves ©2011 MFMER | slide-10 “Snuff” = Moist ground tobacco ©2011 MFMER | slide-11 Type of ST Used in U.S. Chewing Tobacco Snuff National Survey on Drug Use and Health (NSDUH) ©2011 MFMER | slide-12 “Spitless Tobacco” – Star Scientific ©2011 MFMER | slide-13 RJ Reynold’s ©2011 MFMER | slide-14 “Swedish Style” ST ©2011 MFMER | slide-15 Phillip Morris (Altria) ©2011 MFMER | slide-16 New Product: “Fully Dissolvables” ©2011 MFMER
    [Show full text]
  • Medicinal Herbs Quick Reference Guide Revision 2*
    Medicinal Herbs Quick Reference Guide * Revision 2 Julieta Criollo DNM, CHT Doctor of Natural Medicine Clinical Herbal Therapist Wellness Trading Post [email protected] www.wellnesstradingpost.com 604-760-6425 Copyright © 2004–2011 Julieta Criollo All rights reserved. Note to the reader This booklet is intended for educational purposes only. The information contained in it has been compiled from published books and material on plant medicine. Although the information has been reviewed for correctness, the publisher/author does not assume any legal responsibility and/or liability for any errors or omissions. Furthermore, herbal/plant medicine standards (plant identification, medicinal properties, preparations, dosage, safety precautions and contraindications, pharmacology, and therapeutic usage) are continuously evolving and changing as new research and clinical studies are being published and expanding our knowledge. Hence, readers are encouraged and advised to check the most current information available on plant medicine standards and safety. T his information is not intended to be a substitute for professional medical advice. Always seek the advice of a medical doctor or qualified health practitioner prior to starting any new treatment, or with any questions you may have regarding a medical condition. The publisher/author does not assume any legal responsibility and/or liability for the use of the information contained in this booklet. * Revision 1 updates: addition of color bars to the Herb Groups and the various Herb
    [Show full text]
  • Transdermal Nicotine Maintenance Attenuates the Subjective And
    Neuropsychopharmacology (2004) 29, 991–1003 & 2004 Nature Publishing Group All rights reserved 0893-133X/04 $25.00 www.neuropsychopharmacology.org Transdermal Nicotine Maintenance Attenuates the Subjective and Reinforcing Effects of Intravenous Nicotine, but not Cocaine or Caffeine, in Cigarette-Smoking Stimulant Abusers 1 1 ,1,2 Bai-Fang X Sobel , Stacey C Sigmon and Roland R Griffiths* 1Department of Psychiatry and Behavioral Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 2Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA The effects of transdermal nicotine maintenance on the subjective, reinforcing, and cardiovascular effects of intravenously administered cocaine, caffeine, and nicotine were examined using double-blind procedures in nine volunteers with histories of using tobacco, caffeine, and cocaine. Each participant was exposed to two chronic drug maintenance phases (21 mg/day nicotine transdermal patch and placebo transdermal patch). Within each drug phase, the participant received intravenous injections of placebo, cocaine (15 and 30 mg/70 kg), caffeine (200 and 400 mg/70 kg), and nicotine (1.0 and 2.0 mg/70 kg) in mixed order across days. Subjective and cardiovascular data were collected before and repeatedly after drug or placebo injection. Reinforcing effects were also assessed after each injection with a Drug vs Money Multiple-Choice Form. Intravenous cocaine produced robust dose-related increases in subjective and reinforcing effects; these effects were not altered by nicotine maintenance. Intravenous caffeine produced elevations on several subjective ratings; nicotine maintenance did not affect these ratings. Under the placebo maintenance condition, intravenous nicotine produced robust dose-related subjective effects, with maximal increases similar to the high dose of cocaine; nicotine maintenance significantly decreased the subjective and reinforcing effects of intravenous nicotine.
    [Show full text]